Nomura Holdings, Inc.
Nomura Holdings, Inc. (NMR) Stock Competitors & Peer Comparison
See (NMR) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Capital Markets Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NMR | $6.68 | -1.62% | 19.7B | 8.79 | $0.76 | +5.76% |
| MS-PI | $24.97 | +0.48% | 229.5B | 3.18 | $7.86 | +2.59% |
| MS-PE | $25.50 | +0.03% | 228.6B | 3.25 | $7.86 | +2.59% |
| MS-PK | $23.80 | -0.01% | 228.5B | 3.03 | $7.86 | +2.59% |
| MS-PF | $25.18 | -0.12% | 228.3B | 3.21 | $7.86 | +2.59% |
| MS | $142.56 | -0.31% | 227.7B | 16.16 | $8.82 | +2.59% |
| MS-PA | $21.58 | -0.69% | 227.3B | 2.75 | $7.86 | +2.59% |
| GS-PA | $21.83 | +0.60% | 225B | 0.42 | $51.53 | +1.65% |
| GS-PD | $21.12 | +0.05% | 223.8B | 0.41 | $51.53 | +1.65% |
| GS-PC | $21.57 | +0.00% | 223.3B | 1.72 | $12.53 | +1.65% |
Stock Comparison
NMR vs MS-PI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PI has a market cap of 229.5B. Regarding current trading prices, NMR is priced at $6.68, while MS-PI trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PI's P/E ratio is 3.18. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PI's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PI. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PI's competition here
NMR vs MS-PE Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PE has a market cap of 228.6B. Regarding current trading prices, NMR is priced at $6.68, while MS-PE trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PE's P/E ratio is 3.25. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PE's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PE. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PE's competition here
NMR vs MS-PK Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PK has a market cap of 228.5B. Regarding current trading prices, NMR is priced at $6.68, while MS-PK trades at $23.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PK's P/E ratio is 3.03. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PK's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PK's competition here
NMR vs MS-PF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PF has a market cap of 228.3B. Regarding current trading prices, NMR is priced at $6.68, while MS-PF trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PF's P/E ratio is 3.21. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PF's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PF's competition here
NMR vs MS Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS has a market cap of 227.7B. Regarding current trading prices, NMR is priced at $6.68, while MS trades at $142.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS's P/E ratio is 16.16. In terms of profitability, NMR's ROE is +0.10%, compared to MS's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS's competition here
NMR vs MS-PA Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PA has a market cap of 227.3B. Regarding current trading prices, NMR is priced at $6.68, while MS-PA trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PA's P/E ratio is 2.75. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PA's ROE of +0.13%. Regarding short-term risk, NMR is less volatile compared to MS-PA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MS-PA's competition here
NMR vs GS-PA Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS-PA has a market cap of 225B. Regarding current trading prices, NMR is priced at $6.68, while GS-PA trades at $21.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS-PA's P/E ratio is 0.42. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PA's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to GS-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PA's competition here
NMR vs GS-PD Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS-PD has a market cap of 223.8B. Regarding current trading prices, NMR is priced at $6.68, while GS-PD trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS-PD's P/E ratio is 0.41. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PD's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to GS-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PD's competition here
NMR vs GS-PC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS-PC has a market cap of 223.3B. Regarding current trading prices, NMR is priced at $6.68, while GS-PC trades at $21.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS-PC's P/E ratio is 1.72. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PC's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to GS-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PC's competition here
NMR vs GS Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS has a market cap of 222.1B. Regarding current trading prices, NMR is priced at $6.68, while GS trades at $723.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS's P/E ratio is 15.93. In terms of profitability, NMR's ROE is +0.10%, compared to GS's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to GS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GS's competition here
NMR vs SCHW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SCHW has a market cap of 177.9B. Regarding current trading prices, NMR is priced at $6.68, while SCHW trades at $97.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SCHW's P/E ratio is 26.32. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW's ROE of +0.16%. Regarding short-term risk, NMR is less volatile compared to SCHW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SCHW's competition here
NMR vs SCHW-PD Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SCHW-PD has a market cap of 175.8B. Regarding current trading prices, NMR is priced at $6.68, while SCHW-PD trades at $24.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SCHW-PD's P/E ratio is 8.97. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PD's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to SCHW-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PD's competition here
NMR vs GS-PJ Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS-PJ has a market cap of 68.9B. Regarding current trading prices, NMR is priced at $6.68, while GS-PJ trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS-PJ's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PJ's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to GS-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PJ's competition here
NMR vs GS-PK Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GS-PK has a market cap of 64.7B. Regarding current trading prices, NMR is priced at $6.68, while GS-PK trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GS-PK's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PK's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to GS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PK's competition here
NMR vs MS-PQ Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PQ has a market cap of 41B. Regarding current trading prices, NMR is priced at $6.68, while MS-PQ trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PQ's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PQ's ROE of +0.14%. Regarding short-term risk, NMR is more volatile compared to MS-PQ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PQ's competition here
NMR vs MS-PP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PP has a market cap of 40.9B. Regarding current trading prices, NMR is priced at $6.68, while MS-PP trades at $25.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PP's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PP's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PP. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PP's competition here
NMR vs SCHW-PJ Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SCHW-PJ has a market cap of 35B. Regarding current trading prices, NMR is priced at $6.68, while SCHW-PJ trades at $19.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SCHW-PJ's P/E ratio is 6.94. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PJ's ROE of +0.16%. Regarding short-term risk, NMR is more volatile compared to SCHW-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PJ's competition here
NMR vs RJF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, RJF has a market cap of 33.8B. Regarding current trading prices, NMR is priced at $6.68, while RJF trades at $167.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas RJF's P/E ratio is 16.41. In terms of profitability, NMR's ROE is +0.10%, compared to RJF's ROE of +0.24%. Regarding short-term risk, NMR is more volatile compared to RJF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF's competition here
NMR vs TW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, TW has a market cap of 32.6B. Regarding current trading prices, NMR is priced at $6.68, while TW trades at $137.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas TW's P/E ratio is 56.71. In terms of profitability, NMR's ROE is +0.10%, compared to TW's ROE of +0.09%. Regarding short-term risk, NMR is less volatile compared to TW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TW's competition here
NMR vs MS-PL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PL has a market cap of 31.7B. Regarding current trading prices, NMR is priced at $6.68, while MS-PL trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PL's P/E ratio is 2.52. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PL's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PL's competition here
NMR vs LPLA Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, LPLA has a market cap of 30.8B. Regarding current trading prices, NMR is priced at $6.68, while LPLA trades at $385.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas LPLA's P/E ratio is 26.66. In terms of profitability, NMR's ROE is +0.10%, compared to LPLA's ROE of +0.38%. Regarding short-term risk, NMR is less volatile compared to LPLA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LPLA's competition here
NMR vs IBKR Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, IBKR has a market cap of 28.5B. Regarding current trading prices, NMR is priced at $6.68, while IBKR trades at $65.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas IBKR's P/E ratio is 33.97. In terms of profitability, NMR's ROE is +0.10%, compared to IBKR's ROE of +0.18%. Regarding short-term risk, NMR is less volatile compared to IBKR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check IBKR's competition here
NMR vs MS-PO Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MS-PO has a market cap of 27.5B. Regarding current trading prices, NMR is priced at $6.68, while MS-PO trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MS-PO's P/E ratio is 2.19. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PO's ROE of +0.13%. Regarding short-term risk, NMR is more volatile compared to MS-PO. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PO's competition here
NMR vs HLI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, HLI has a market cap of 13.5B. Regarding current trading prices, NMR is priced at $6.68, while HLI trades at $192.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas HLI's P/E ratio is 33.13. In terms of profitability, NMR's ROE is +0.10%, compared to HLI's ROE of +0.20%. Regarding short-term risk, NMR is less volatile compared to HLI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HLI's competition here
NMR vs JEF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, JEF has a market cap of 11.9B. Regarding current trading prices, NMR is priced at $6.68, while JEF trades at $57.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas JEF's P/E ratio is 22.21. In terms of profitability, NMR's ROE is +0.10%, compared to JEF's ROE of +0.06%. Regarding short-term risk, NMR is less volatile compared to JEF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check JEF's competition here
NMR vs EVR Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, EVR has a market cap of 11.7B. Regarding current trading prices, NMR is priced at $6.68, while EVR trades at $302.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas EVR's P/E ratio is 28.87. In terms of profitability, NMR's ROE is +0.10%, compared to EVR's ROE of +0.28%. Regarding short-term risk, NMR is less volatile compared to EVR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check EVR's competition here
NMR vs SF-PB Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SF-PB has a market cap of 11.6B. Regarding current trading prices, NMR is priced at $6.68, while SF-PB trades at $24.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SF-PB's P/E ratio is 3.62. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PB's ROE of +0.11%. Regarding short-term risk, NMR is more volatile compared to SF-PB. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PB's competition here
NMR vs SF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SF has a market cap of 11.5B. Regarding current trading prices, NMR is priced at $6.68, while SF trades at $111.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SF's P/E ratio is 21.33. In terms of profitability, NMR's ROE is +0.10%, compared to SF's ROE of +0.11%. Regarding short-term risk, NMR is more volatile compared to SF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF's competition here
NMR vs FRHC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, FRHC has a market cap of 10.7B. Regarding current trading prices, NMR is priced at $6.68, while FRHC trades at $175.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas FRHC's P/E ratio is 125.41. In terms of profitability, NMR's ROE is +0.10%, compared to FRHC's ROE of +0.07%. Regarding short-term risk, NMR is less volatile compared to FRHC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FRHC's competition here
NMR vs SCE-PJ Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SCE-PJ has a market cap of 8.9B. Regarding current trading prices, NMR is priced at $6.68, while SCE-PJ trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SCE-PJ's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to SCE-PJ's ROE of N/A. Regarding short-term risk, NMR is more volatile compared to SCE-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCE-PJ's competition here
NMR vs XP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, XP has a market cap of 8.5B. Regarding current trading prices, NMR is priced at $6.68, while XP trades at $16.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas XP's P/E ratio is 10.33. In terms of profitability, NMR's ROE is +0.10%, compared to XP's ROE of +0.23%. Regarding short-term risk, NMR is less volatile compared to XP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check XP's competition here
NMR vs MKTX Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MKTX has a market cap of 7.8B. Regarding current trading prices, NMR is priced at $6.68, while MKTX trades at $207.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MKTX's P/E ratio is 36.12. In terms of profitability, NMR's ROE is +0.10%, compared to MKTX's ROE of +0.16%. Regarding short-term risk, NMR is less volatile compared to MKTX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MKTX's competition here
NMR vs VIRT Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, VIRT has a market cap of 6.5B. Regarding current trading prices, NMR is priced at $6.68, while VIRT trades at $43.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas VIRT's P/E ratio is 12.54. In terms of profitability, NMR's ROE is +0.10%, compared to VIRT's ROE of +0.24%. Regarding short-term risk, NMR is less volatile compared to VIRT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check VIRT's competition here
NMR vs MARA Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MARA has a market cap of 6B. Regarding current trading prices, NMR is priced at $6.68, while MARA trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MARA's P/E ratio is -15.74. In terms of profitability, NMR's ROE is +0.10%, compared to MARA's ROE of -0.10%. Regarding short-term risk, NMR is less volatile compared to MARA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MARA's competition here
NMR vs PIPR Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, PIPR has a market cap of 5.6B. Regarding current trading prices, NMR is priced at $6.68, while PIPR trades at $314.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas PIPR's P/E ratio is 27.39. In terms of profitability, NMR's ROE is +0.10%, compared to PIPR's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to PIPR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PIPR's competition here
NMR vs RJF-PA Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, RJF-PA has a market cap of 5.4B. Regarding current trading prices, NMR is priced at $6.68, while RJF-PA trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas RJF-PA's P/E ratio is 3.54. In terms of profitability, NMR's ROE is +0.10%, compared to RJF-PA's ROE of +0.24%. Regarding short-term risk, NMR is more volatile compared to RJF-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF-PA's competition here
NMR vs MC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MC has a market cap of 5.3B. Regarding current trading prices, NMR is priced at $6.68, while MC trades at $71.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MC's P/E ratio is 27.84. In terms of profitability, NMR's ROE is +0.10%, compared to MC's ROE of +0.44%. Regarding short-term risk, NMR is less volatile compared to MC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MC's competition here
NMR vs LAZ Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, LAZ has a market cap of 5.1B. Regarding current trading prices, NMR is priced at $6.68, while LAZ trades at $54.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas LAZ's P/E ratio is 18.61. In terms of profitability, NMR's ROE is +0.10%, compared to LAZ's ROE of +0.48%. Regarding short-term risk, NMR is less volatile compared to LAZ. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LAZ's competition here
NMR vs RJF-PB Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, RJF-PB has a market cap of 5.1B. Regarding current trading prices, NMR is priced at $6.68, while RJF-PB trades at $25.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas RJF-PB's P/E ratio is 3.57. In terms of profitability, NMR's ROE is +0.10%, compared to RJF-PB's ROE of +0.24%. Regarding short-term risk, NMR is more volatile compared to RJF-PB. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF-PB's competition here
NMR vs BGC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BGC has a market cap of 4.8B. Regarding current trading prices, NMR is priced at $6.68, while BGC trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BGC's P/E ratio is 37.50. In terms of profitability, NMR's ROE is +0.10%, compared to BGC's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to BGC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGC's competition here
NMR vs SNEX Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SNEX has a market cap of 4.6B. Regarding current trading prices, NMR is priced at $6.68, while SNEX trades at $94.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SNEX's P/E ratio is 16.03. In terms of profitability, NMR's ROE is +0.10%, compared to SNEX's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to SNEX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SNEX's competition here
NMR vs PJT Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, PJT has a market cap of 4.5B. Regarding current trading prices, NMR is priced at $6.68, while PJT trades at $182.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas PJT's P/E ratio is 32.10. In terms of profitability, NMR's ROE is +0.10%, compared to PJT's ROE of +0.99%. Regarding short-term risk, NMR is less volatile compared to PJT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PJT's competition here
NMR vs IREN Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, IREN has a market cap of 4B. Regarding current trading prices, NMR is priced at $6.68, while IREN trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas IREN's P/E ratio is -53.48. In terms of profitability, NMR's ROE is +0.10%, compared to IREN's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to IREN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check IREN's competition here
NMR vs FUTU Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, FUTU has a market cap of 2.8B. Regarding current trading prices, NMR is priced at $6.68, while FUTU trades at $162.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas FUTU's P/E ratio is 27.28. In terms of profitability, NMR's ROE is +0.10%, compared to FUTU's ROE of +0.23%. Regarding short-term risk, NMR is less volatile compared to FUTU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUTU's competition here
NMR vs MRX Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MRX has a market cap of 2.7B. Regarding current trading prices, NMR is priced at $6.68, while MRX trades at $37.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MRX's P/E ratio is 11.40. In terms of profitability, NMR's ROE is +0.10%, compared to MRX's ROE of +0.23%. Regarding short-term risk, NMR is less volatile compared to MRX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MRX's competition here
NMR vs SF-PC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SF-PC has a market cap of 2.4B. Regarding current trading prices, NMR is priced at $6.68, while SF-PC trades at $23.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SF-PC's P/E ratio is 3.51. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PC's ROE of +0.11%. Regarding short-term risk, NMR is more volatile compared to SF-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PC's competition here
NMR vs HUT Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, HUT has a market cap of 2.3B. Regarding current trading prices, NMR is priced at $6.68, while HUT trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas HUT's P/E ratio is -30.80. In terms of profitability, NMR's ROE is +0.10%, compared to HUT's ROE of -0.09%. Regarding short-term risk, NMR is less volatile compared to HUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HUT's competition here
NMR vs CIFR Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, CIFR has a market cap of 2.1B. Regarding current trading prices, NMR is priced at $6.68, while CIFR trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas CIFR's P/E ratio is -16.21. In terms of profitability, NMR's ROE is +0.10%, compared to CIFR's ROE of -0.18%. Regarding short-term risk, NMR is less volatile compared to CIFR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CIFR's competition here
NMR vs WULF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, WULF has a market cap of 2B. Regarding current trading prices, NMR is priced at $6.68, while WULF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas WULF's P/E ratio is -15.00. In terms of profitability, NMR's ROE is +0.10%, compared to WULF's ROE of -0.42%. Regarding short-term risk, NMR is less volatile compared to WULF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WULF's competition here
NMR vs CIFRW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, CIFRW has a market cap of 1.8B. Regarding current trading prices, NMR is priced at $6.68, while CIFRW trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas CIFRW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to CIFRW's ROE of -0.18%. Regarding short-term risk, NMR is less volatile compared to CIFRW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CIFRW's competition here
NMR vs PWP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, PWP has a market cap of 1.8B. Regarding current trading prices, NMR is priced at $6.68, while PWP trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas PWP's P/E ratio is -98.57. In terms of profitability, NMR's ROE is +0.10%, compared to PWP's ROE of +0.03%. Regarding short-term risk, NMR is less volatile compared to PWP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PWP's competition here
NMR vs DFIN Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, DFIN has a market cap of 1.8B. Regarding current trading prices, NMR is priced at $6.68, while DFIN trades at $65.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas DFIN's P/E ratio is 21.55. In terms of profitability, NMR's ROE is +0.10%, compared to DFIN's ROE of +0.21%. Regarding short-term risk, NMR is less volatile compared to DFIN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DFIN's competition here
NMR vs SF-PD Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SF-PD has a market cap of 1.8B. Regarding current trading prices, NMR is priced at $6.68, while SF-PD trades at $17.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SF-PD's P/E ratio is 2.62. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PD's ROE of +0.11%. Regarding short-term risk, NMR is more volatile compared to SF-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PD's competition here
NMR vs TIGR Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, TIGR has a market cap of 1.7B. Regarding current trading prices, NMR is priced at $6.68, while TIGR trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas TIGR's P/E ratio is 22.71. In terms of profitability, NMR's ROE is +0.10%, compared to TIGR's ROE of +0.13%. Regarding short-term risk, NMR is less volatile compared to TIGR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TIGR's competition here
NMR vs BGCP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BGCP has a market cap of 1.7B. Regarding current trading prices, NMR is priced at $6.68, while BGCP trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BGCP's P/E ratio is 40.27. In terms of profitability, NMR's ROE is +0.10%, compared to BGCP's ROE of +0.23%. Regarding short-term risk, NMR is less volatile compared to BGCP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGCP's competition here
NMR vs HKIB Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, HKIB has a market cap of 1.5B. Regarding current trading prices, NMR is priced at $6.68, while HKIB trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas HKIB's P/E ratio is 6.68. In terms of profitability, NMR's ROE is +0.10%, compared to HKIB's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to HKIB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HKIB's competition here
NMR vs COWN Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, COWN has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $6.68, while COWN trades at $38.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas COWN's P/E ratio is 17.64. In terms of profitability, NMR's ROE is +0.10%, compared to COWN's ROE of +0.07%. Regarding short-term risk, NMR is more volatile compared to COWN. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check COWN's competition here
NMR vs BTBT Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BTBT has a market cap of 958.7M. Regarding current trading prices, NMR is priced at $6.68, while BTBT trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BTBT's P/E ratio is -5.36. In terms of profitability, NMR's ROE is +0.10%, compared to BTBT's ROE of -0.21%. Regarding short-term risk, NMR is less volatile compared to BTBT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTBT's competition here
NMR vs AC Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, AC has a market cap of 788M. Regarding current trading prices, NMR is priced at $6.68, while AC trades at $37.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas AC's P/E ratio is 20.71. In terms of profitability, NMR's ROE is +0.10%, compared to AC's ROE of +0.04%. Regarding short-term risk, NMR is more volatile compared to AC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check AC's competition here
NMR vs OPY Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, OPY has a market cap of 778M. Regarding current trading prices, NMR is priced at $6.68, while OPY trades at $74.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas OPY's P/E ratio is 11.10. In terms of profitability, NMR's ROE is +0.10%, compared to OPY's ROE of +0.09%. Regarding short-term risk, NMR is less volatile compared to OPY. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check OPY's competition here
NMR vs BITF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BITF has a market cap of 711.6M. Regarding current trading prices, NMR is priced at $6.68, while BITF trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BITF's P/E ratio is -7.11. In terms of profitability, NMR's ROE is +0.10%, compared to BITF's ROE of -0.15%. Regarding short-term risk, NMR is less volatile compared to BITF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BITF's competition here
NMR vs FUFU Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, FUFU has a market cap of 614.9M. Regarding current trading prices, NMR is priced at $6.68, while FUFU trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas FUFU's P/E ratio is 377.00. In terms of profitability, NMR's ROE is +0.10%, compared to FUFU's ROE of +0.42%. Regarding short-term risk, NMR is less volatile compared to FUFU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUFU's competition here
NMR vs FUFUW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, FUFUW has a market cap of 598M. Regarding current trading prices, NMR is priced at $6.68, while FUFUW trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas FUFUW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to FUFUW's ROE of +0.42%. Regarding short-term risk, NMR is less volatile compared to FUFUW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUFUW's competition here
NMR vs AMRK Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, AMRK has a market cap of 538M. Regarding current trading prices, NMR is priced at $6.68, while AMRK trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas AMRK's P/E ratio is 13.92. In terms of profitability, NMR's ROE is +0.10%, compared to AMRK's ROE of +0.06%. Regarding short-term risk, NMR is less volatile compared to AMRK. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AMRK's competition here
NMR vs HIVE Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, HIVE has a market cap of 475.8M. Regarding current trading prices, NMR is priced at $6.68, while HIVE trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas HIVE's P/E ratio is -111.00. In terms of profitability, NMR's ROE is +0.10%, compared to HIVE's ROE of -0.01%. Regarding short-term risk, NMR is less volatile compared to HIVE. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HIVE's competition here
NMR vs COHN Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, COHN has a market cap of 336.8M. Regarding current trading prices, NMR is priced at $6.68, while COHN trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas COHN's P/E ratio is -10.64. In terms of profitability, NMR's ROE is +0.10%, compared to COHN's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to COHN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check COHN's competition here
NMR vs GHL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GHL has a market cap of 282M. Regarding current trading prices, NMR is priced at $6.68, while GHL trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GHL's P/E ratio is -10.27. In terms of profitability, NMR's ROE is +0.10%, compared to GHL's ROE of +0.04%. Regarding short-term risk, NMR is more volatile compared to GHL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GHL's competition here
NMR vs MFH Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MFH has a market cap of 224.2M. Regarding current trading prices, NMR is priced at $6.68, while MFH trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MFH's P/E ratio is -44.00. In terms of profitability, NMR's ROE is +0.10%, compared to MFH's ROE of -0.23%. Regarding short-term risk, NMR is less volatile compared to MFH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MFH's competition here
NMR vs SWIN Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SWIN has a market cap of 222.1M. Regarding current trading prices, NMR is priced at $6.68, while SWIN trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SWIN's P/E ratio is -7.34. In terms of profitability, NMR's ROE is +0.10%, compared to SWIN's ROE of -0.40%. Regarding short-term risk, NMR is less volatile compared to SWIN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SWIN's competition here
NMR vs WHG Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, WHG has a market cap of 172.9M. Regarding current trading prices, NMR is priced at $6.68, while WHG trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas WHG's P/E ratio is 460.75. In terms of profitability, NMR's ROE is +0.10%, compared to WHG's ROE of +0.00%. Regarding short-term risk, NMR is less volatile compared to WHG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WHG's competition here
NMR vs PROP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, PROP has a market cap of 166.1M. Regarding current trading prices, NMR is priced at $6.68, while PROP trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas PROP's P/E ratio is -0.72. In terms of profitability, NMR's ROE is +0.10%, compared to PROP's ROE of -0.87%. Regarding short-term risk, NMR is less volatile compared to PROP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PROP's competition here
NMR vs SIEB Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SIEB has a market cap of 156M. Regarding current trading prices, NMR is priced at $6.68, while SIEB trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SIEB's P/E ratio is 8.39. In terms of profitability, NMR's ROE is +0.10%, compared to SIEB's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to SIEB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SIEB's competition here
NMR vs BTM Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BTM has a market cap of 121.1M. Regarding current trading prices, NMR is priced at $6.68, while BTM trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BTM's P/E ratio is -34.93. In terms of profitability, NMR's ROE is +0.10%, compared to BTM's ROE of -0.32%. Regarding short-term risk, NMR is less volatile compared to BTM. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTM's competition here
NMR vs BTCS Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, BTCS has a market cap of 120.3M. Regarding current trading prices, NMR is priced at $6.68, while BTCS trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas BTCS's P/E ratio is -3.00. In terms of profitability, NMR's ROE is +0.10%, compared to BTCS's ROE of -1.09%. Regarding short-term risk, NMR is less volatile compared to BTCS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTCS's competition here
NMR vs CLSKW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, CLSKW has a market cap of 110.3M. Regarding current trading prices, NMR is priced at $6.68, while CLSKW trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas CLSKW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to CLSKW's ROE of +0.05%. Regarding short-term risk, NMR is less volatile compared to CLSKW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CLSKW's competition here
NMR vs TCJH Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, TCJH has a market cap of 89.6M. Regarding current trading prices, NMR is priced at $6.68, while TCJH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas TCJH's P/E ratio is -1.61. In terms of profitability, NMR's ROE is +0.10%, compared to TCJH's ROE of -0.55%. Regarding short-term risk, NMR is less volatile compared to TCJH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TCJH's competition here
NMR vs SRL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SRL has a market cap of 88.9M. Regarding current trading prices, NMR is priced at $6.68, while SRL trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SRL's P/E ratio is -5.88. In terms of profitability, NMR's ROE is +0.10%, compared to SRL's ROE of -0.02%. Regarding short-term risk, NMR is less volatile compared to SRL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SRL's competition here
NMR vs GRYP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GRYP has a market cap of 78.4M. Regarding current trading prices, NMR is priced at $6.68, while GRYP trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GRYP's P/E ratio is -4.50. In terms of profitability, NMR's ROE is +0.10%, compared to GRYP's ROE of +1.33%. Regarding short-term risk, NMR is less volatile compared to GRYP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRYP's competition here
NMR vs HGBL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, HGBL has a market cap of 76.5M. Regarding current trading prices, NMR is priced at $6.68, while HGBL trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas HGBL's P/E ratio is 18.08. In terms of profitability, NMR's ROE is +0.10%, compared to HGBL's ROE of +0.07%. Regarding short-term risk, NMR is less volatile compared to HGBL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HGBL's competition here
NMR vs GRDI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GRDI has a market cap of 68.1M. Regarding current trading prices, NMR is priced at $6.68, while GRDI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GRDI's P/E ratio is 3.20. In terms of profitability, NMR's ROE is +0.10%, compared to GRDI's ROE of -2.49%. Regarding short-term risk, NMR is less volatile compared to GRDI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRDI's competition here
NMR vs PLUT Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, PLUT has a market cap of 45.9M. Regarding current trading prices, NMR is priced at $6.68, while PLUT trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas PLUT's P/E ratio is -59.80. In terms of profitability, NMR's ROE is +0.10%, compared to PLUT's ROE of -0.10%. Regarding short-term risk, NMR is less volatile compared to PLUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PLUT's competition here
NMR vs TOP Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, TOP has a market cap of 44.2M. Regarding current trading prices, NMR is priced at $6.68, while TOP trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas TOP's P/E ratio is -14.91. In terms of profitability, NMR's ROE is +0.10%, compared to TOP's ROE of -0.08%. Regarding short-term risk, NMR is less volatile compared to TOP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TOP's competition here
NMR vs MDBH Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MDBH has a market cap of 44.2M. Regarding current trading prices, NMR is priced at $6.68, while MDBH trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MDBH's P/E ratio is 3.10. In terms of profitability, NMR's ROE is +0.10%, compared to MDBH's ROE of +0.25%. Regarding short-term risk, NMR is more volatile compared to MDBH. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MDBH's competition here
NMR vs SDIG Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SDIG has a market cap of 42M. Regarding current trading prices, NMR is priced at $6.68, while SDIG trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SDIG's P/E ratio is -3.51. In terms of profitability, NMR's ROE is +0.10%, compared to SDIG's ROE of -0.96%. Regarding short-term risk, NMR is more volatile compared to SDIG. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SDIG's competition here
NMR vs GREE Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GREE has a market cap of 25.2M. Regarding current trading prices, NMR is priced at $6.68, while GREE trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GREE's P/E ratio is -0.88. In terms of profitability, NMR's ROE is +0.10%, compared to GREE's ROE of +0.38%. Regarding short-term risk, NMR is less volatile compared to GREE. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GREE's competition here
NMR vs ARBK Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, ARBK has a market cap of 24M. Regarding current trading prices, NMR is priced at $6.68, while ARBK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas ARBK's P/E ratio is -0.37. In terms of profitability, NMR's ROE is +0.10%, compared to ARBK's ROE of +3.56%. Regarding short-term risk, NMR is less volatile compared to ARBK. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ARBK's competition here
NMR vs SAI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SAI has a market cap of 18.5M. Regarding current trading prices, NMR is priced at $6.68, while SAI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SAI's P/E ratio is -2.88. In terms of profitability, NMR's ROE is +0.10%, compared to SAI's ROE of -0.33%. Regarding short-term risk, NMR is less volatile compared to SAI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SAI's competition here
NMR vs NCPLW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, NCPLW has a market cap of 18.4M. Regarding current trading prices, NMR is priced at $6.68, while NCPLW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas NCPLW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to NCPLW's ROE of -0.28%. Regarding short-term risk, NMR is less volatile compared to NCPLW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check NCPLW's competition here
NMR vs NCPL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, NCPL has a market cap of 16.1M. Regarding current trading prices, NMR is priced at $6.68, while NCPL trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas NCPL's P/E ratio is -0.20. In terms of profitability, NMR's ROE is +0.10%, compared to NCPL's ROE of -0.28%. Regarding short-term risk, NMR is less volatile compared to NCPL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check NCPL's competition here
NMR vs MEGL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MEGL has a market cap of 14M. Regarding current trading prices, NMR is priced at $6.68, while MEGL trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MEGL's P/E ratio is -14.50. In terms of profitability, NMR's ROE is +0.10%, compared to MEGL's ROE of -0.04%. Regarding short-term risk, NMR is less volatile compared to MEGL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MEGL's competition here
NMR vs ABTS Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, ABTS has a market cap of 10.9M. Regarding current trading prices, NMR is priced at $6.68, while ABTS trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas ABTS's P/E ratio is -12.05. In terms of profitability, NMR's ROE is +0.10%, compared to ABTS's ROE of -0.08%. Regarding short-term risk, NMR is less volatile compared to ABTS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ABTS's competition here
NMR vs MIGI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, MIGI has a market cap of 9.9M. Regarding current trading prices, NMR is priced at $6.68, while MIGI trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas MIGI's P/E ratio is -0.35. In terms of profitability, NMR's ROE is +0.10%, compared to MIGI's ROE of +58.60%. Regarding short-term risk, NMR is less volatile compared to MIGI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MIGI's competition here
NMR vs ATIF Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, ATIF has a market cap of 7.6M. Regarding current trading prices, NMR is priced at $6.68, while ATIF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas ATIF's P/E ratio is -2.06. In terms of profitability, NMR's ROE is +0.10%, compared to ATIF's ROE of -0.77%. Regarding short-term risk, NMR is less volatile compared to ATIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ATIF's competition here
NMR vs WAI Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, WAI has a market cap of 4.7M. Regarding current trading prices, NMR is priced at $6.68, while WAI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas WAI's P/E ratio is -0.15. In terms of profitability, NMR's ROE is +0.10%, compared to WAI's ROE of -0.40%. Regarding short-term risk, NMR is less volatile compared to WAI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WAI's competition here
NMR vs GSIW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GSIW has a market cap of 4.6M. Regarding current trading prices, NMR is priced at $6.68, while GSIW trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GSIW's P/E ratio is -0.26. In terms of profitability, NMR's ROE is +0.10%, compared to GSIW's ROE of -0.46%. Regarding short-term risk, NMR is less volatile compared to GSIW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GSIW's competition here
NMR vs LGHLW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, LGHLW has a market cap of 2M. Regarding current trading prices, NMR is priced at $6.68, while LGHLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas LGHLW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to LGHLW's ROE of -1.53%. Regarding short-term risk, NMR is less volatile compared to LGHLW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LGHLW's competition here
NMR vs GRDIW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, GRDIW has a market cap of 1.6M. Regarding current trading prices, NMR is priced at $6.68, while GRDIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas GRDIW's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to GRDIW's ROE of -2.49%. Regarding short-term risk, NMR is less volatile compared to GRDIW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRDIW's competition here
NMR vs SAITW Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, SAITW has a market cap of 964.2K. Regarding current trading prices, NMR is priced at $6.68, while SAITW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas SAITW's P/E ratio is -6.77. In terms of profitability, NMR's ROE is +0.10%, compared to SAITW's ROE of -0.33%. Regarding short-term risk, NMR is less volatile compared to SAITW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SAITW's competition here
NMR vs LGHL Comparison July 2025
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 19.7B. In comparison, LGHL has a market cap of 316.4K. Regarding current trading prices, NMR is priced at $6.68, while LGHL trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 8.79, whereas LGHL's P/E ratio is -0.02. In terms of profitability, NMR's ROE is +0.10%, compared to LGHL's ROE of -1.53%. Regarding short-term risk, NMR is less volatile compared to LGHL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LGHL's competition here